Summary:
The Diabetes Research Center is conducting a 6-month clinical study for Type 2 Diabetes patients currently on a rapid-acting insulin regimen associated with a long-acting insulin, which is evaluating Albiglutide in combination with Lantus insulin.
Qualified Participants Must:
• Be 18 years of age or older
•
Have a diagnosis of type 2 diabetes
Qualified Participants May Receive:
Free study related diabetes care and compensation for time and travel.